Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for fatigue symptoms in long COVID
jRCT2031220510Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in post-COVID syndrome and coronavirus disease 2019 (COVID-19) comparing Donepezil group with Placebo group (2 arms). Primary endpoint: Change in Chalder Fatigue-11 score at 3 weeks. Started Jan 2023; status: completed.
02
Drugs
donepezil
03
Conditions
post-COVID syndromecoronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2031220510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220510.